Fatigue is one of the most common and debilitating symptoms experienced by
cancer patients, yet until recent years it has received little systematic a
ttention, due in part to the lack of adequate instruments to measure fatigu
e. The primary aim of this report is to further validate a recently develop
ed measure of fatigue for use with cancer patients: the Fatigue Symptom Inv
entory (FSI). This 13-item self-report measure was designed to measure the
intensity and duration of fatigue and its interference with quality of life
. The FSI was originally validated in a sample of breast cancer patients an
d a sample of healthy individuals. In this study, the FSI was evaluated in
an outpatient sample that included male and female cancer patients. as well
as some older patients, with a variety of cancer diagnoses, A seven-item i
nterference scale was found to have good internal consistency, with alpha c
oefficients above 0.90. Convergent validity was demonstrated via comparison
s with an existing measure of fatigue. Construct validity was demonstrated
via comparisons with measure of life satisfaction and depression as well as
comparisons among subgroups of patients expected to differ in their experi
ence of fatigue. Overall, the FSI was further established as a valid and re
liable measure of fatigue in cancer patients. The potential application of
this measure in psychosocial oncology research is discussed.